European Journal of Dermatology

, Volume 24, Issue 2, pp 147–153 | Cite as

Small-fibre neuropathies and skin: news and perspectives for dermatologists

  • Laurent Misery
  • Céline Bodere
  • Steeve Genestet
  • Fabien Zagnoli
  • Pascale Marcorelles
Review Article
  • 91 Downloads

Abstract

Small-fibre neuropathies (SFNs) can be defined as diseases of small nerve fibres. Because their symptoms are mainly located in the skin in the initial stages, dermatologists may frequently be confronted with these diseases. Moreover, skin biopsies and the subsequent measurement of intraepidermal nerve fibre density have become a widely accepted technique to investigate the structural integrity of small nerve fibres. The pathogenesis of injury to small nerve fibres is poorly understood. It probably depends on the cause. SCN9A-gene variants have been reported. Diabetes mellitus is one of the main causes of SFNs. Some causes of SFNs are very well-known to dermatologists: Gougerot-Sjögren syndrome, lupus, sarcoidosis and Fabry disease. We also discuss erythermalgia, prurigo nodularis, nummular eczema, burning mouth syndrome and sensitive skin as SFNs.

Key words

small-fibre neuropathy PGP9.5 nerve Gougerot-Sjögren syndrome sarcoidosis Fabry disease erythermalgia pruritus burning mouth syndrome sensitive skin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998; 44: 47–59.PubMedCrossRefGoogle Scholar
  2. 2.
    Oaklander AL. Neuropathic itch. Semin Cutan Med Surg 2011; 30: 87–92.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Dalsgaard CJ, Bjorklund H, Jonsson CE, Hermansson A, Dahl D. Distribution of neurofilament-immunoreactive nerve fibers in human skin. Histochemistry 1984; 81: 111–114.PubMedCrossRefGoogle Scholar
  4. 4.
    Wang L, Hilliges M, Jernberg T, Wiesleb-Edtröm D, Johansson O. Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res 1990; 261: 25–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Hilliges M, Wang L, Johansson O. Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermatol 1995; 104: 134–137.PubMedCrossRefGoogle Scholar
  6. 6.
    Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17: 903–912.PubMedCrossRefGoogle Scholar
  7. 7.
    Lauria G, Bakkers M, Schmitz C, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15: 202–207.PubMedCrossRefGoogle Scholar
  8. 8.
    Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002; 26: 173–188.PubMedCrossRefGoogle Scholar
  9. 9.
    Tavee J, Zhou L. Small fiber neuropathy: A burning problem. Cleve Clin J Med 2009; 76: 297–305.PubMedCrossRefGoogle Scholar
  10. 10.
    Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008; 131: 1912–1925.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep 2011; 15: 193–200.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Singleton JR, Bixby B, Russell JW, et al. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 2008; 13: 218–227.PubMedCrossRefGoogle Scholar
  13. 13.
    Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004; 108: 248–257.PubMedCrossRefGoogle Scholar
  14. 14.
    Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29–36.PubMedCrossRefGoogle Scholar
  15. 15.
    Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve 2004; 29: 734–747.PubMedCrossRefGoogle Scholar
  16. 16.
    Novak V, Freimer L, Kissel JT, et al. Autonomic impairment in painful neuropathy. Neurology 2001; 56: 861–868.PubMedCrossRefGoogle Scholar
  17. 17.
    Teoh HL, Chow A, Wilder-Smith EP. Skin wrinkling for diagnosing small fibre neuropathy: comparison with epidermal nerve density and sympathetic skin response. J Neurol Neurosurg Psychiatry 2008; 79: 835–837.PubMedCrossRefGoogle Scholar
  18. 18.
    Datema M, Gert van Dijk J, Hoitsma E. The diagnostic value of water immersion skin wrinkling and Neuropads in small fiber neuropathy. Clin Neurophysiol 2012; 123: 2074–2079.PubMedCrossRefGoogle Scholar
  19. 19.
    Sommer C, Lauria G. Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 2007; 6: 632–642.PubMedCrossRefGoogle Scholar
  20. 20.
    Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996; 47: 1042–1048.PubMedCrossRefGoogle Scholar
  21. 21.
    Panoutsopoulou IG, Wendelschafer-Crabb G, Hodges JS, Kennedy WR. Skin blister and skin biopsy to quantify epidermal nerves: a comparative study. Neurology 2009; 72: 1205–1210.PubMedCrossRefGoogle Scholar
  22. 22.
    Lauria G, Cornblath DR, Johansson O, et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005; 12: 747–758.PubMedCrossRefGoogle Scholar
  23. 23.
    Wendelschafer-Crabb G, Kennedy WR, Walk D. Morphological features of nerves in skin biopsies. J Neurol Sci 2006; 242: 15–21.PubMedCrossRefGoogle Scholar
  24. 24.
    Lauria G, Morbin M, Lombardi R, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003; 61: 631–636.PubMedCrossRefGoogle Scholar
  25. 25.
    McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55: 1513–1520.PubMedCrossRefGoogle Scholar
  26. 26.
    Lauria G, Lombardi R, Borgna M, et al. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 2005; 10: 202–208.PubMedCrossRefGoogle Scholar
  27. 27.
    Holland NR, Stocks A, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997; 48: 708–711.PubMedCrossRefGoogle Scholar
  28. 28.
    Hoeijmakers JG, Merkies IS, Gerrits MM, Waxman SG, Faber CG. Genetic aspects of sodium channelopathy in small fiber neuropathy. Clin Genet 2012; 82: 351–358.PubMedCrossRefGoogle Scholar
  29. 29.
    Casanova-Molla J, Morales M, Planas-Rigol E, et al. Epidermal Langerhans cells in small fiber neuropathies. Pain 2012; 153: 982–989.PubMedCrossRefGoogle Scholar
  30. 30.
    Hoitsma E, Reulen JP, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 2004; 227: 119–130.PubMedCrossRefGoogle Scholar
  31. 31.
    Fauchais AL, Richard L, Gondran G, et al. Neuropathie des petites fibres au cours du syndrome de Sjögren primitif. Rev Med Interne 2011; 32: 142–148.PubMedCrossRefGoogle Scholar
  32. 32.
    Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16: 287–297.PubMedCrossRefGoogle Scholar
  33. 33.
    Roguedas AM, Youinou P, Lemasson G, Pennec YL, Misery L. Primary Gougerot-Sjogren syndrome: a dermatological approach. J Eur Acad Dermatol Venereol 2006; 20: 243–247.PubMedCrossRefGoogle Scholar
  34. 34.
    Oxholm P, Oxholm A, Manthorpe R. Epidermal IgG deposits in patients with chronic inflammatory connective tissue diseases: diagnostic value and correlation to clinical and immunological parameters in patients with primary Sjögren’s syndrome. Cli Exp Rheumatol 1987; 5: 5–9.Google Scholar
  35. 35.
    Roguedas AM, Pers JO, Lemasson G, et al. Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren’s syndrome. J Autoimmun 2010; 35: 241–247.PubMedCrossRefGoogle Scholar
  36. 36.
    Omdal R, Mellgren SI, Gøransson L, et al. Small nerve fiber involvement in systemic lupus erythematosus: a controlled study. Arthritis Rheum 2002; 46: 1228–1232.PubMedCrossRefGoogle Scholar
  37. 37.
    Tavee J, Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep 2011; 15: 201–206.PubMedCrossRefGoogle Scholar
  38. 38.
    Voorter CE, Drent M, Hoitsma E, Faber KG, van den Berg-Loonen EM. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis 2005; 22: 129–132.Google Scholar
  39. 39.
    Schiffmann R. Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy. Acta Neurol Belg 2006; 106: 61–65.PubMedGoogle Scholar
  40. 40.
    Biegstraaten M, Hollak CE, Bakkers M, Faber CG, Aerts JM, van Schaik IN. Small fiber neuropathy in Fabry disease. Mol Genet Metab 2012; 106: 135–141.PubMedCrossRefGoogle Scholar
  41. 41.
    Üçeyler N, Kahn AK, Kramer D, et al. Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. BMC Neurol 2013; 13: 47.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Schiffmann R, Kopp JB, Austin HA, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285: 2743–2749.PubMedCrossRefGoogle Scholar
  43. 43.
    Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002; 58: 115–119.PubMedCrossRefGoogle Scholar
  44. 44.
    Herrmann DN, McDermott MP, Sowden JE, et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study. Neurology 2006; 66: 657–661.CrossRefGoogle Scholar
  45. 45.
    Misery L. L’erythermalgie hereditaire: un modele pour comprendre l’erythermalgie? Ann Dermatol Venereol 2007; 134: 479–480.PubMedCrossRefGoogle Scholar
  46. 46.
    Davis MD, Weenig RH, Genebriera J, Wendelschafer-Crabb G, Kennedy WR, Sandroni P. Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density. J Am Acad Dermatol 2006; 55: 519–522.PubMedCrossRefGoogle Scholar
  47. 47.
    Dabby R. Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations. Curr Neurol Neurosci Rep 2012; 12: 76–83.PubMedCrossRefGoogle Scholar
  48. 48.
    Schuhknecht B, Marziniak M, Wissel A, et al. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy. Br J Dermatol 2011; 165: 85–91.PubMedCrossRefGoogle Scholar
  49. 49.
    Maddison B, Parsons A, Sangueza O, Sheehan DJ, Yosipovitch G. Retrospective study of intraepidermal nerve fiber distribution in biopsies of patients with nummular eczema. Am J Dermatopathol 2011; 33: 621–623.PubMedCrossRefGoogle Scholar
  50. 50.
    Woda A, Tubert-Jeannin S, Bouhassira D, et al. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005; 116: 396–406.PubMedCrossRefGoogle Scholar
  51. 51.
    Bodéré C, Woda A. La douleur orofaciale idiopathique: une douleur fonctionnelle. Douleur Analg 2009; 22: 89–95.CrossRefGoogle Scholar
  52. 52.
    Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol 2012; 123: 71–77PubMedCrossRefGoogle Scholar
  53. 53.
    Forssell H, Jääskeläinen S, Tenovuo O, S H. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99: 41–47PubMedCrossRefGoogle Scholar
  54. 54.
    Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332–337.PubMedCrossRefGoogle Scholar
  55. 55.
    Kaplan I, Levin T, Papoiu AD, et al. Thermal sensory and pain thresholds in the tongue and chin change with age, but are not altered in burning mouth syndrome. Skin Res Technol 2011; 17: 196–200.PubMedCrossRefGoogle Scholar
  56. 56.
    Berardesca E, Fluhr JW, Maibach HI. Sensitive skin syndrome. New York: Taylor & Francis; 2006. 281 p.CrossRefGoogle Scholar
  57. 57.
    Misery L. How the skin reacts to environmental factors. J Eur Acad Dermatol Venereol 2007; 21Suppl 2: 5–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Stander S, Schneider SW, Weishaupt C, Luger TA, Misery L. Putative neuronal mechanisms of sensitive skin. Exp Dermatol 2009; 18: 417–423.PubMedCrossRefGoogle Scholar
  59. 59.
    Ho TW, Backonja M, Ma J, Leibensperger H, Froman S, Polydefkis M. Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies. Pain 2009; 141: 19–24.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2014

Authors and Affiliations

  • Laurent Misery
    • 1
    • 2
    • 3
  • Céline Bodere
    • 1
    • 4
  • Steeve Genestet
    • 2
    • 5
  • Fabien Zagnoli
    • 1
    • 2
    • 6
  • Pascale Marcorelles
    • 1
    • 2
    • 7
  1. 1.Laboratory of Neurosciences of BrestUniversity of Western BrittanyBrestFrance
  2. 2.Breton Competence Centre of RareNeuro-Muscular Diseases and Neuropathies with Cutaneous-Mucosal SymptomsBrestFrance
  3. 3.Department of dermatologyArmed Forces Instruction Hospital Clermont-TonnerreBrestFrance
  4. 4.Department of odontologyArmed Forces Instruction Hospital Clermont-TonnerreBrestFrance
  5. 5.Department of clinical neurophysiologyArmed Forces Instruction Hospital Clermont-TonnerreBrestFrance
  6. 6.Department of neurologyArmed Forces Instruction Hospital Clermont-TonnerreBrestFrance
  7. 7.Department of pathologyUniversity Hospital of BrestBrestFrance

Personalised recommendations